Advagraf Prolonged Release Hard Capsules 5 mg
Product details
Registration number: SIN14135P
Classification: Prescription Only
Active ingredients: Tacrolimus monohydrate 5.1 mg eqv anhydrous Tacrolimus 5.0 mg
Strength: 5.0 mg
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Registrant: ASTELLAS PHARMA SINGAPORE PTE. LTD.
ATC code: L04AD02
HSA approval date: 16 April 2012
Manufacturer(s):
- Astellas Ireland Co., Ltd
- Astellas Pharma Inc. Toyama Technology Center (Intermediate Granules)
Manufacturing country/countries: IRELAND; JAPAN
What are the HSA registration number and classification for Advagraf Prolonged Release Hard Capsules 5 mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14135P
Classification: Prescription Only
What active ingredients and strength are recorded for Advagraf Prolonged Release Hard Capsules 5 mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Tacrolimus monohydrate 5.1 mg eqv anhydrous Tacrolimus 5.0 mg
Strength: 5.0 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Advagraf Prolonged Release Hard Capsules 5 mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Who is the recorded registrant for Advagraf Prolonged Release Hard Capsules 5 mg?
According to the HSA dataset updated 7 August 2026:
Registrant: ASTELLAS PHARMA SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for Advagraf Prolonged Release Hard Capsules 5 mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Astellas Ireland Co., Ltd
- Astellas Pharma Inc. Toyama Technology Center (Intermediate Granules)
Manufacturing country/countries: IRELAND; JAPAN
Where can I look up Advagraf Prolonged Release Hard Capsules 5 mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14135P or the exact product name Advagraf Prolonged Release Hard Capsules 5 mg. The general register link does not preselect this product.
What are the source dates for this Advagraf Prolonged Release Hard Capsules 5 mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Advagraf Prolonged Release Hard Capsules 5 mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14135P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)